External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience ASGCT Breakthroughs 2024
Roche and Genentech at

ASGCT Breakthroughs 2024

November 19 - November 20
Chicago, USA / Virtual (Hybrid)
asgct.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
02:00 PM
Duration 1hr Chicago, USA
Wearable Device Outcomes From EMBARK, a Pivotal Phase 3 Study in Patients With Duchenne Muscular Dystrophy Treated With Delandistrogene Moxeparvovec
Paul Strijbos, Craig McDonald, Alexander Murphy, Stefanie Mason, Xiao Ni, Carol Reid, Marianna Manfrini, Jacob Elkins, Louise Rodino-Klapac, Francesco Muntoni
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.